Abstract
Fluorescent-antibody reagents were prepared against vegetative cells of representative strains of each physiological group and toxin type of Clostridium botulinum known to have caused botulism in humans. A fluorescent-antibody reagent was also prepared for C. botulinum type G, which has been isolated from autopsy specimens but which has not clearly been implicated in botulism. These fluorescent-antibody reagents were evaluated against 200 strains of C. botulinum and 64 strains of other clostridia. Each reagent reacted with at least a 2+ intensity with all of the strains in its same toxin type and physiological group. Ninety-seven percent of the strains gave at least a 3+ reaction with the homologous group or toxin type reagent. Some cross-reactions occurred with reagents against different toxin type strains within a physiological group; there was less cross-reaction between physiological groups and very little reactivity of C. botulinum reagents with nontoxigenic organisms. Absorption of cross-reacting antibodies was not successful. Certain reagents could be used for presumptive laboratory identification of C. botulinum strains causing botulism, especially in infants. The type G reagent provided a good means of identifying C. botulinum type G, which lacks the lipase marker and whose toxigenicity may be more difficult to demonstrate in mixed cultures. There was a serological relationship between C. botulinum type G and some strains of Clostridium subterminale. This relationship provided evidence of differences between strains of C. botulinum type G isolated in two different countries.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnon S. S., Midura T. F., Damus K., Wood R. M., Chin J. Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet. 1978 Jun 17;1(8077):1273–1277. doi: 10.1016/s0140-6736(78)91264-3. [DOI] [PubMed] [Google Scholar]
- Giménez D. F., Ciccarelli A. S. Another type of Clostridium botulinum. Zentralbl Bakteriol Orig. 1970;215(2):221–224. [PubMed] [Google Scholar]
- Hoffman R. E., Pincomb B. J., Skeels M. R. Type F infant botulism. Am J Dis Child. 1982 Mar;136(3):270–271. doi: 10.1001/archpedi.1982.03970390084021. [DOI] [PubMed] [Google Scholar]
- Midura T. F., Inouye Y., Bodily H. L. Use of immunofluorescence to identify Clostridium botulinum types A, B, and E. Public Health Rep. 1967 Mar;82(3):275–279. [PMC free article] [PubMed] [Google Scholar]
- Solomon H. M., Lynt R. K., Jr, Kautter D. A., Lilly T., Jr Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum. Appl Microbiol. 1971 Feb;21(2):295–299. doi: 10.1128/am.21.2.295-299.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sonnabend O., Sonnabend W., Heinzle R., Sigrist T., Dirnhofer R., Krech U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis. 1981 Jan;143(1):22–27. doi: 10.1093/infdis/143.1.22. [DOI] [PubMed] [Google Scholar]